TVD-101-001H
A Phase 1b/2 Multicenter, Open-label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants with Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Condition: HCC | Last Updated: 5 Feb 23 | Status: open
View Full Study
